Atsuhiko Taniguchi
Hachioji, 1920392, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Development of Novel Lysosome-Targeting Chimera by Non-covalent-Type Fc-IGF2 Complex (Fc-LYTAC) for Target Membrane Protein Degradation.
Journal: Chemical & pharmaceutical bulletin
Published: June 03, 2026
Molecular functions and applications of peptide agonists acting on mouse neuromedin U receptor 1.
Journal: Bioorganic & medicinal chemistry
Published: March 26, 2026
Evaluation of Readthrough Efficiency of Negamycin Derivatives against Nonsense Mutations in Muscular Dystrophy Genes.
Journal: Biological & pharmaceutical bulletin
Published: February 23, 2026
Structure-Activity Relationship Study of Affinity Peptides for the Fc Site of Human Immunoglobulin G.
Journal: Chemical & pharmaceutical bulletin
Published: December 17, 2025
Exploring the Substrate Flexibility of GrsB Thioesterase Leads to the Structural Reassignment of a Gramicidin S Variant.
Journal: Chembiochem : a European journal of chemical biology
Published: May 22, 2025
Development of Water-Soluble 3-Nitro-2-Pyridinesulfenate for Disulfide Bond Formation of Peptide Under Aqueous Conditions.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: March 04, 2025
Backbone resonance assignments of the C-terminal thioesterase domain of tyrocidine synthetase C.
Journal: Biomolecular NMR assignments
Published: October 17, 2024
Structure Derivatization of IgG-Binding Peptides and Analysis of Their Secondary Structure by Circular Dichroism Spectroscopy.
Journal: Chemical & pharmaceutical bulletin
Published: September 23, 2024
Detection of Active SARS-CoV-2 3CL Protease in Infected Cells Using Activity-Based Probes with a 2,6-Dichlorobenzoyloxymethyl Ketone Reactive Warhead.
Journal: ACS chemical biology
Published: April 26, 2024
Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1.
Journal: ACS medicinal chemistry letters
Published: February 27, 2024
Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity.
Journal: ACS medicinal chemistry letters
Published: September 20, 2023
Last Updated: 09/26/2026